Profile data is unavailable for this security.
About the company
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
- Revenue in CAD (TTM)157.64m
- Net income in CAD8.01m
- Incorporated2021
- Employees98.00
- LocationMedexus Pharmaceuticals Inc35 Nixon Road, Unit 1BOLTON L7E 1K1CanadaCAN
- Phone+1 (514) 762-2626
- Websitehttps://www.medexus.com/en_US
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medipharm Labs Corp | 36.99m | -13.61m | 32.32m | 166.00 | -- | 0.6484 | -- | 0.8738 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
| Briacell Therapeutics Corp | 0.00 | -17.17m | 34.22m | 5.00 | -- | -- | -- | -- | -1.11 | -1.11 | 0.00 | -0.6881 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Avicanna Inc | 22.07m | -7.25m | 35.11m | 38.00 | -- | -- | -- | 1.59 | -0.0808 | -0.0808 | 0.2477 | -0.0055 | 1.12 | 3.07 | 12.26 | 580,708.40 | -36.83 | -67.17 | -282.36 | -167.73 | 47.29 | 46.36 | -32.86 | -368.82 | 0.3163 | -10.44 | 0.1834 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Medicus Pharma Ltd | 0.00 | -8.00m | 35.55m | -- | -- | 32.41 | -- | -- | -1.25 | -1.25 | 0.00 | 0.068 | 0.00 | -- | -- | -- | -539.96 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -7.90 | 0.00 | -- | -- | -- | -300.86 | -- | -- | -- |
| Simply Better Brands Corp | 108.78m | -33.04m | 36.52m | -- | -- | -- | -- | 0.3357 | -0.4606 | -0.4606 | 1.53 | -0.0682 | 2.84 | 6.79 | 22.87 | -- | -86.36 | -63.90 | -460.44 | -215.48 | 58.69 | -- | -30.37 | -29.46 | 0.298 | -8.19 | 1.65 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 37.86m | -- | -- | -- | -- | 51.39 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| Medexus Pharmaceuticals Inc | 157.64m | 8.01m | 39.14m | 98.00 | 4.41 | 0.9727 | 2.45 | 0.2483 | 0.3629 | 0.3629 | 7.25 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,608,578.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Charlotte's Web Holdings Inc | 79.37m | -41.57m | 39.34m | 164.00 | -- | 0.6189 | -- | 0.4957 | -0.271 | -0.271 | 0.517 | 0.4043 | 0.3668 | 1.07 | 27.08 | 483,988.00 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Immunoprecise Antibodies Ltd | 23.68m | -14.27m | 41.95m | 102.00 | -- | 0.8419 | -- | 1.77 | -0.4156 | -0.4156 | 0.6889 | 1.39 | 0.2939 | 5.25 | 6.76 | 170,420.70 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| IntelGenx Technologies Corp. | 1.43m | -15.03m | 41.96m | 48.00 | -- | -- | -- | 29.31 | -0.086 | -0.086 | 0.0082 | -0.1198 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Decibel Cannabis Company Inc | 115.96m | -1.77m | 44.96m | -- | -- | 0.974 | 33.56 | 0.3878 | -0.0045 | -0.0045 | 0.2739 | 0.1129 | 0.817 | 1.51 | 7.66 | -- | -1.25 | -3.55 | -2.04 | -5.19 | 36.10 | 38.83 | -1.53 | -7.13 | 0.3685 | 1.21 | 0.5122 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
| Microbix Biosystems Inc | 23.84m | 4.06m | 45.32m | 69.00 | 11.16 | 1.63 | 8.30 | 1.90 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
